Steward Partners Investment Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Hold |
50,865
| – | – | ﹤0.01% | 1635 |
|
|
2025
Q1 | $269K | Buy |
50,865
+36,300
| +249% | +$192K | ﹤0.01% | 1502 |
|
|
2024
Q4 | $98.5K | Buy |
14,565
+9,982
| +218% | +$67.5K | ﹤0.01% | 1993 |
|
|
2024
Q3 | $30.2K | Buy |
4,583
+3,000
| +190% | +$19.8K | ﹤0.01% | 2468 |
|
|
2024
Q2 | $11.9K | Buy |
1,583
+1,000
| +172% | +$7.5K | ﹤0.01% | 2748 |
|
|
2024
Q1 | $5.81K | Buy |
583
+83
| +17% | +$828 | ﹤0.01% | 2997 |
|
|
2023
Q4 | $4.93K | Buy |
+500
| New | +$4.93K | ﹤0.01% | 2964 |
|